ASX:EVEFood, Beverage & TobaccoPackaged Foods & Meats
EVE HEALTH GROUP ORD
$0.020
$0.001 (4.76%)
Day Range
$0.020 - $0.020
52 Week Range
$0.018 - $0.044
Volume
12.50K
Avg Volume (10D)
219.10K
Market Cap
$5.70M
Price Chart
Market Statistics
Open$0.020
Previous Close$0.021
Day High$0.020
Day Low$0.020
52 Week High$0.044
52 Week Low$0.018
Valuation
Market Cap5.70M
Shares Outstanding284.88M
Price to Book1.59
Trading Activity
Volume12.50K
Value Traded250.00
Bid$0.020 × 285,051
Ask$0.023 × 348,124
Performance
1 Day0.00%
5 Day5.00%
13 Week-8.70%
52 Week-47.50%
YTD0.00%
Technical Indicators
RSI (14)45.35
50-Day SMA$0.021
200-Day SMA$0.028
Latest News
Biotechnology
EVE Health Group Raises $0.9m to Advance Reformulated Pharmaceutical Pipeline
EVE Health Group raises $0.904m via placement to push reformulated drug delivery pipeline, accelerating IP, regulatory work and licensing talks.
1 min read
Biotechnology
EVE Health Advances Reformulated Drugs Targeting Sexual Health and Cardiovascular Markets
EVE Health advances reformulated ED/PE sprays and Apixaban delivery, expanding its sexual health and cardiovascular pipeline.
2 min read
Biotechnology
EVE Health Group Launches Libbo ED Treatment and Men’s Health Platform
EVE Health (ASX: EVE) launches Libbo ED treatment and men’s health platform, unveiling an end-to-end digital pathway for nationwide access and scalable revenue.
1 min read
Biotechnology
EVE Health Signs Telehealth Agreement with hubMed to Support Dyspro and Libbo Launches
EVE Health Group (ASX: EVE) has entered into a telehealth services agreement with hubMed to enhance the quality and continuity of care for patients using EVE’s therapeutic products including Dyspro for dysmenorrhoea and Libbo for erectile dysfunction.
2 min read